Reporting Organization: | Gavi, The Vaccine Alliance |
---|---|
Total Budget ($CAD): | $ 15,000,000 |
Timeframe: | March 9, 2011 - December 31, 2012 |
Status: | Completion |
Contact Information: | Unspecified |
Unspecified
Sub-Saharan Africa - $ 8,730,000.00 (58.20%) | |
|
|
Southeast Asia - $ 1,605,000.00 (10.70%) | |
|
|
South Asia - $ 1,305,000.00 (8.70%) | |
|
|
East Asia - $ 1,170,000.00 (7.80%) | |
|
|
North Africa - $ 1,170,000.00 (7.80%) | |
|
|
Central Asia - $ 720,000.00 (4.80%) | |
|
|
Europe - $ 150,000.00 (1.00%) | |
|
|
South America - $ 105,000.00 (0.70%) | |
|
|
Central America - $ 45,000.00 (0.30%) | |
|
Infectious & Communicable Diseases (100 %) | |
|
This grant represents Canada’s institutional support to the GAVI Alliance. The GAVI Alliance uses the funds, along with funding from other donors to achieve its mandate to save children’s lives and protect people’s health by increasing access to immunization in poor countries. GAVI pursues its mission through four strategic goals: accelerating the uptake of new and underused vaccines; contribute to strengthening the capacity of integrated health systems to deliver immunization; increase the predictability of global financing and improve the sustainability of national financing for immunization; and shape vaccine markets. This project represents an additional contribution to the project “GAVI Alliance – Institutional Support – 2011-2015”.
Gender and age: | Children, girls Children, boys Under-5 children |
---|---|
Total Direct Population: | Unspecified |
Unspecified
Return to topUnspecified
Key results achieved from 2011 to 2014 include: 352 million children were fully immunized with GAVI support, and 3.1 million deaths were prevented. Between 2011 (start of the new GAVI Strategy for 2011-2015) and 2013, pneumococcal and rotavirus vaccines have been introduced in 73 and 34 countries respectively.